Author

Giuseppe Vittorio De Socio

Clinica di Malattie Infettive, Azienda Ospedaliero-Universitaria di Perugia. Ospedale "Santa Maria - Cited by 2,864 - Infectious Diseases - Clinical medicine - HIV - AIDS - HCV

Biography

Giuseppe Vittorio De Socio is currently working as a Professor. His/Her research Giuseppe Vittorio De Socio is serving as an editorial member and reviewer of several international reputed journals. He/She has successfully completed his Administrative responsibilities.
Title
Cited by
Year
Predictive value of National Early Warning Score 2 (NEWS2) for intensive care unit admission in patients with SARS-CoV-2 infection
A Gidari, GV De Socio, S Sabbatini, D FrancisciInfectious Diseases 52 (10), 698-704, 2020202
105
2020
Effect of high-titer convalescent plasma on progression to severe respiratory failure or death in hospitalized patients with COVID-19 pneumonia: a randomized clinical trial
F Menichetti, P Popoli, M Puopolo, SS Alegiani, G Tiseo, A Bartoloni, ...JAMA network open 4 (11), e2136246-e2136246, 2021202
47
2021
Factors associated with weight gain in people treated with dolutegravir
L Taramasso, P Bonfanti, E Ricci, G Orofino, N Squillace, B Menzaghi, ...Open Forum Infectious Diseases 7 (6), ofaa195, 2020202
45
2020
Clusterization of co-morbidities and multi-morbidities among persons living with HIV: a cross-sectional study
P Maggi, CR Santoro, M Nofri, E Ricci, N De Gennaro, C Bellacosa, ...BMC infectious diseases 19, 1-9, 2019201
31
2019
Delivery in asymptomatic Italian woman with SARS-CoV-2 infection
GV De Socio, L Malincarne, S Arena, S Troiani, S Benedetti, B Camilloni, ...Mediterranean Journal of Hematology and Infectious Diseases 12 (1), 2020202
25
2020
The effect of switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) on liver enzymes, glucose, and lipid profile
N Squillace, E Ricci, B Menzaghi, GV De Socio, S Passerini, C Martinelli, ...Drug Design, Development and Therapy, 5515-55,
20
2020
National Early Warning Score 2 (NEWS2) better predicts critical Coronavirus Disease 2019 (COVID-19) illness than COVID-GRAM, a multi-centre study
National Early Warning Score 2 (NEWS2) better predicts critical Coronavirus Disease 20 (COVID-) illness than COVID-GRAM, a multi-centre studyGV De Socio, A Gidari, F Sicari, M Palumbo, D FrancisciInfection 49 (5), 1033-1038, 2021202
19
2021
Dolutegravir is not associated with weight gain in antiretroviral therapy experienced geriatric patients living with HIV
G Guaraldi, S Calza, J Milic, A Calcagno, E Focà, M Rota, S Renzetti, ...AIDS (London, England) 35 (6), 939, 2021202
19
2021
Smoking habits in HIV-infected people compared with the general population in Italy: a cross-sectional study
GV De Socio, M Pasqualini, E Ricci, P Maggi, G Orofino, N Squillace, ...BMC Public Health 20 (1), 1-10, 2020202
18
2020
Statins and aspirin in the prevention of cardiovascular disease among HIV-positive patients between controversies and unmet needs: review of the literature and suggestions for …
P Maggi, GV De Socio, S Cicalini, M D’Abbraccio, G Dettorre, A Di Biagio, ...AIDS research and therapy 16, 1-8, 2019201
15
2019
A study of SARS-CoV-2 epidemiology in Italy: from early days to secondary effects after social distancing
MC Traini, C Caponi, R Ferrari, GV De SocioInfectious Diseases 52 (12), 866-876, 2020202
11
2020
Durability of dolutegravir-based regimens: a 5-year prospective observational study
L Taramasso, A De Vito, ED Ricci, G Orofino, N Squillace, B Menzaghi, ...AIDS Patient Care and STDs 35 (9), 342-353, 2021202
11
2021
Modelling the epidemic 2019-nCoV event in Italy: a preliminary note
Modelling the epidemic 201-nCoV event in Italy: a preliminary noteMC Traini, C Caponi, GV De SociomedRxiv, 2020.03. 14.20034884, 2020202
9
2020
Bone safety of dolutegravir-containing regimens in people living with HIV: Results from a real-world cohort
P Bonfanti, A De Vito, E Ricci, B Menzaghi, G Orofino, N Squillace, ...Infection and Drug Resistance, 2291-2300, 2020202
8
2020
Positioning of darunavir/cobicistat-containing antiretroviral regimens in real life: results from a large multicentre observational prospective cohort (SCOLTA)
L Taramasso, E Ricci, A Cascio, L Valsecchi, B Menzaghi, N Squillace, ...AIDS Research and Therapy 1 (1), 1-8, 2019201
6
2019
Metabolic syndrome and body weight in people living with HIV infection: analysis of differences observed in three different cohort studies over a decade
L Taramasso, P Bonfanti, E Ricci, P Maggi, G Orofino, N Squillace, ...HIV medicine 23 (1), 70-79, 2022202
6
2022
Smoking habits in human immunodeficiency virus-infected people from Italy: a cross-sectional analysis of the STOPSHIV cohort
GV De Socio, P Maggi, E Ricci, G Orofino, N Squillace, B Menzaghi, ...AIDS Research and Human Retroviruses 36 (1), 19-26, 2020202
5
2020
Dangerous liaisons? The role of inflammation and comorbidities in HIV and SARS-CoV-2 infection
P Maggi, E Ricci, V Messina, A Salzillo, F Simeone, A Iodice, GV SocioExpert Review of Clinical Immunology 17 (3), 201-208, 2021202
4
2021
Accelerate Pheno™ system in sepsis by Gram-negative pathogens: four months of hospital experience
GV De Socio, A Belati, R Paggi, A D’Arpino, A Moretti, F Allegrucci, ...New Microbiol 3 (1), 6-12, 2020202
4
2020
Reversibility of central nervous system adverse events in course of ART
L Taramasso, G Orofino, E Ricci, B Menzaghi, GV De Socio, N Squillace, ...Viruses 1 (5), 1028, 2022202
4
2022

Referred From: https://scholar.google.com/citations?user=MmlgkucAAAAJ&hl=en&oi=ao

Cited by
Citations 2864
h-index 29
i10-index 79
Recommended Journals
Open Access Journals